| Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological … N Kumar, N Sharma, R Khera, R Gupta, S Mehan Metabolic brain disease 36, 911-925, 2021 | 47 | 2021 |
| The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis N Kumar, NK Sahoo, S Mehan Multiple sclerosis and related disorders 71, 104547, 2023 | 24 | 2023 |
| Connection between JAK/STAT and PPARγ signaling during the progression of multiple sclerosis: Insights into the modulation of T-cells and immune responses in the brain N Kumar, N Sharma, S Mehan Current molecular pharmacology 14 (5), 823-837, 2021 | 24 | 2021 |
| Metabolic syndromes responsible for cervical cancer and advancement of nanocarriers for efficient targeted drug delivery-A review S Ashique, A Upadhyay, N Kumar, S Chauhan, N Mishra Advances in Cancer Biology-Metastasis 4, 100041, 2022 | 23 | 2022 |
| Dysregulation of SIRT-1 signaling in multiple sclerosis and neuroimmune disorders: a systematic review of SIRTUIN activators as potential immunomodulators and their influences … N Sharma, A Shandilya, N Kumar, S Mehan Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | 23 | 2021 |
| Effect of natural adenylcyclase/cAMP/CREB signalling activator forskolin against intra-striatal 6-OHDA-lesioned Parkinson’s rats: preventing mitochondrial, motor and … M Alharbi, A Alshammari, G Kaur, S Kalra, S Mehan, M Suri, S Chhabra, ... Molecules 27 (22), 7951, 2022 | 16 | 2022 |
| Forskolin, an adenylcyclase/cAMP/CREB signaling activator restoring myelin-associated oligodendrocyte destruction in experimental ethidium bromide model of multiple sclerosis T Kapoor, S Mehan, M Suri, N Sharma, N Kumar, AS Narula, ... Cells 11 (18), 2771, 2022 | 13 | 2022 |
| Current landscape of therapeutics for the management of hypertension-a review N Fatima, S Ashique, A Upadhyay, S Kumar, H Kumar, N Kumar, P Kumar Current Drug Delivery 21 (5), 662-682, 2024 | 6 | 2024 |
| Unveiling the role of exosomes as cellular messengers in neurodegenerative diseases and their potential therapeutic implications S Ashique, N Kumar, N Mishra, S Muthu, RL Rajendran, C Balakumar, ... Pathology-Research and Practice, 155451, 2024 | 5 | 2024 |
| Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders S Ashique, N Mishra, S Mantry, A Garg, N Kumar, M Gupta, SK Kar, ... Naunyn-Schmiedeberg's Archives of Pharmacology, 1-32, 2024 | 4 | 2024 |
| A critical review on the role of probiotics in lung cancer biology and prognosis S Ashique, N Mishra, A Garg, N Kumar, Z Khan, S Mohanto, ... Archivos de Bronconeumología, 2024 | 4 | 2024 |
| Unlocking the possibilities of therapeutic potential of silymarin and silibinin against neurodegenerative diseases-a mechanistic overview S Ashique, S Mohanto, N Kumar, S Nag, A Mishra, A Biswas, M Rihan, ... European Journal of Pharmacology, 176906, 2024 | 3 | 2024 |
| The SIRT-1/nrf2/HO-1 Axis: guardians of neuronal health in neurological disorders P Sethi, S Mehan, Z Khan, PK Maurya, N Kumar, A Kumar, A Tiwari, ... Behavioural brain research, 115280, 2024 | 2 | 2024 |
| Ayurvedic Treatment of Bipolar Disorder R Kumar, C Singh, S Tyagi, N Kumar American Journal of Biomedical Research 9 (1), 5-9, 2021 | 2 | 2021 |
| Formulation of Solid Lipid Nanoparticles Loaded with Rosiglitazone and Probiotic: Optimization and In-vitro Characterization N Kumar, N Tyagi, S Mehan, AP Singh Recent Patents on Nanotechnology 18 (4), 527-542, 2024 | 1 | 2024 |
| Regulation of Plant Hormones Under Abiotic Stress Conditions in Plants P Kumar, S Ashique, N Kumar, A Jain, H Sharma, SN Pandey, A Singh Plant Secondary Metabolites and Abiotic Stress, 243-276, 2024 | 1 | 2024 |
| Interplay Between Gut-microbiota and Neurodegeneration S Ashique, R Pal, S Kumar, B Verma, N Kumar, I Kahwa, A Farid, ... Advances in Diagnostics and Immunotherapeutics for Neurodegenerative …, 2024 | 1 | 2024 |
| Role of Synbiotics on Modulation of Inflammation B Verma, S Ashique, N Mishra, N Kumar, N Tyagi, S Kumar, D Ingawale, ... Synbiotics in Human Health: Biology to Drug Delivery, 25-54, 2024 | 1 | 2024 |
| A critical review on SGLT2 inhibitors for diabetes mellitus, renal health, and cardiovascular conditions N Kumar, B Kumar, S Ashique, S Yasmin, K Venkatesan, A Islam, ... Diabetes Research and Clinical Practice, 112050, 2025 | | 2025 |
| Enhanced Neuroprotection in Experiment Multiple Sclerosis through Combined Rosiglitazone and Probiotic-Loaded Solid Lipid Nanoparticles: Modulation of Cellular Signaling Pathways N Kumar, N Tyagi, S Mehan, AP Singh CNS & Neurological Disorders-Drug Targets, 2024 | | 2024 |
Sidharth MehanProfessor in Division of Neuroscience, Dept. of Pharmacology, ISF College of Pharmacy, Punjab, Indiaכתובת אימייל מאומתת בדומיין isfcp.org